Health Care - HeadlinesA Latest News

Light
Dark

Showing 1 to 10 of 32 news articles

The FDA scrutinizes Novo Nordisk's Wegovy ad for misleading claims, as the company navigates a competitive weight loss market image

Novo Nordisk Wegovy Ad Busted by FDA Like Sosa at the Airport

Mon 09 February, 2026 17:46
3 minutes to read

Novo Nordisk is suing Hims & Hers for allegedly selling unapproved copies of its Wegovy weight-loss drug image

Wegovy Wars Novo Nordisk Sues Hims & Hers in Weight-Loss Drug Duel

Mon 09 February, 2026 17:35
2 minutes to read

Patient advocates rally against the import of foreign drugs, citing safety concerns and regulatory loopholes. image

Foreign Drugs Face Flintstone Fury

Thu 08 January, 2026 22:04
4 minutes to read

The new GLP-1 pills offer a potential alternative to injections for weight management. image

Obesity Pill Revolution Arrives New Hope or False Promise

Sat 10 January, 2026 13:00
3 minutes to read

Abivax shares surged in 2025, outpacing European peers, positioning the company for a potential acquisition by a major pharmaceutical player. image

French Biotech Firm Abivax Primed for Massive Buyout

Fri 09 January, 2026 11:54
2 minutes to read

Executives at the JPMorgan Healthcare Conference will address patent expirations, obesity drug developments, and the impact of recent drug pricing agreements. image

Healthcare Industry Faces $300 Billion Patent Cliff Amidst Drug Pricing Deals

Fri 09 January, 2026 21:56
3 minutes to read

OpenAI's acquisition of Torch promises to bring cutting-edge AI solutions to healthcare. image

OpenAI's Potent Elixir Acquisition Unlocks New Health Frontiers

Mon 12 January, 2026 22:47
3 minutes to read

CNBC's Cures initiative sparks immense support for rare disease awareness and research. image

Believe It Rare Disease Awareness Gets Rasengan of Support

Mon 12 January, 2026 19:15
2 minutes to read

Pharma leaders at the JPMorgan Healthcare Conference discuss future growth prospects and strategic priorities. image

Pharma Execs Predict a 'Good' 2026 Major Deals Looming

Fri 16 January, 2026 14:59
3 minutes to read

John Crowley, CEO of BIO, speaks out about the growing influence of China's biotech sector and its potential impact on U.S. innovation. image

China's Biotech Boom: A Rare Disease Dilemma

Tue 20 January, 2026 18:49
3 minutes to read